FDA lifts hold on Rocket Pharma's gene therapy trial
Rocket will also collaborate with investigators to implement an immunomodulatory regimen more closely reflecting that administered in the Phase 1 pediatric cohort
Rocket will also collaborate with investigators to implement an immunomodulatory regimen more closely reflecting that administered in the Phase 1 pediatric cohort
This acquisition expands HGM's healthcare platform capabilities in revenue cycle management
The patient had been battling DFSP for over eight years, enduring multiple recurrences despite three previous surgeries
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
Sarepta has also entered into an agreement with Arrowhead to transfer 2,660,989 shares of Arrowhead common stock in satisfaction of $50 million of the company’s previously announced $100 million milestone payment obligation
Its lead product, Dasynoc, is awaiting FDA approval with a PDUFA date of October 7, 2025
Medical plastics make up about 25 per cent of the 14,000 tons of waste generated daily in US healthcare facilities
The acquired ANDAs represent a market opportunity of about US$ 38 million in the USA
AINU is set to accelerate its expansion footprint, enhance operational capabilities
Subscribe To Our Newsletter & Stay Updated